|
June 26, 2026 — FxNutrition Intelligence
Evidence-driven intelligence for functional nutrition practitioners
A Nutrishify publication • Week of June 26, 2026
|
|
We’re back! After a week away exploring the Mosel Valley, FxN Intelligence is back in your inbox and ready to dig in. Thanks for hanging tight.
|
|
Evidence Spotlight
|
Pea Protein Timing & Glucose
Consuming pea protein 30 minutes before a carbohydrate-rich meal reduced the post-meal blood sugar rise to 0.46 mmol/L — compared to 1.125 mmol/L when consumed alongside the meal and 1.89 mmol/L for the carb-only control. Timing drove the difference, not just protein intake.
This was an acute crossover randomized controlled trial (RCT) in ten healthy adults. Participants consumed a pea protein drink either 30 minutes before or alongside a standard carbohydrate-rich meal, with a carb-only meal as the control. Continuous glucose monitoring, diastolic blood pressure (BP), and satiety scores were tracked over three hours. Both timing conditions outperformed the control; the pre-meal condition showed the largest glucose attenuation and a steeper diastolic BP reduction (−9.2 mmHg at 180 min, p < 0.01). The n=10 sample and single-meal acute design limit generalizability — results should be held loosely for now. Worth noting for practitioners working with blood sugar management: the direction aligns with existing whey protein preload research.
Takeaway: This early evidence suggests the sequence of eating — protein before carbohydrates — may matter as much as protein source for postprandial glucose management, including in plant-based eating patterns.
|
Low-GI Diets & Inflammation
A meta-analysis of 21 randomized controlled trials found low glycemic index (LGI) and low glycemic load (LGL) diets were associated with reductions in body weight, BMI, LDL cholesterol, triglycerides, and multiple inflammatory markers — including C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and leptin — while HDL cholesterol rose.
This PROSPERO-registered meta-analysis pooled 21 RCTs (n = 1,265) comparing LGI/LGL diets to control conditions across multiple metabolic outcomes. Effect sizes were calculated using standardized mean differences (SMDs) with 95% confidence intervals. Nearly all primary outcomes showed statistically significant directional effects, but I² statistics of 82–95% across most markers indicate substantial between-study variability — a meaningful caveat. The breadth of simultaneous improvements spanning lipids, body composition, and inflammation reinforces LGI/LGL eating as a coherent dietary pattern rather than just a blood sugar strategy. Effect sizes should be read as directional signals rather than precise estimates. Adiponectin was the one marker that did not shift significantly.
Takeaway: This data suggests LGI/LGL dietary patterns may favorably modulate body weight, lipid metabolism, and specific inflammatory markers simultaneously — though high heterogeneity across trials means pooled effect sizes warrant cautious interpretation.
|
Astaxanthin in Heart Failure
Eight weeks of astaxanthin supplementation at 20 mg/day significantly reduced two pro-inflammatory markers — TNF-α and monocyte chemoattractant protein-1 (MCP-1) — and lowered very low-density lipoprotein (VLDL) in adults with advanced heart failure (stage C/D). High-sensitivity C-reactive protein (hs-CRP), other lipid fractions, and body measurements did not change significantly.
This double-blind, placebo-controlled RCT enrolled 80 adults with stage C or D heart failure and reduced left ventricular ejection fraction (LVEF below 50%). Participants received 20 mg/day of astaxanthin — a marine-derived antioxidant — or matched placebo for eight weeks. The selective pattern of improvement, with two cytokines and VLDL responding while hs-CRP and other lipids did not, suggests astaxanthin may act on specific inflammatory pathways rather than as a broad anti-inflammatory agent. Single-center Iranian context and sample size may limit generalizability; results registered with the Iranian Registry of Clinical Trials (IRCT20200429047235N3).
Takeaway: This trial adds to the mechanistic picture of how marine-derived antioxidants may fit into a broader dietary support context for cardiovascular conditions — with selective rather than broad anti-inflammatory effects at this dose and duration.
|
|
By The Numbers
75% less
blood sugar spike when pea protein was consumed 30 minutes before carbs vs. with the meal
This pilot RCT tested pea protein timing in healthy adults. Pre-meal pea protein reduced the blood sugar spike to 0.46 mmol/L vs. 1.125 mmol/L when consumed with the meal — and 1.89 mmol/L for carbs alone. Timing changed the outcome.
|
|
|
Clinical Pearl
Low-GI diets improve multiple markers simultaneously
A meta-analysis of 21 RCTs found LGI/LGL diets reduced body weight, BMI, total cholesterol, triglycerides, LDL cholesterol, and inflammatory markers — including CRP, TNF-α, IL-6, and leptin — while raising HDL cholesterol. The consistency across metabolic and inflammatory outcomes suggests systemic benefit beyond glucose control alone. High heterogeneity (I² = 82–95%) means effect sizes are directional, not definitive.
|
|
|
|
Recent Podcasts
|
Essentials: The Science of Eating for Health, Fat Loss & Lean Muscle | Dr. Layne Norton
Huberman Lab • June 25, 2026
Useful if you field frequent client questions on protein, seed oils, and sweeteners. Dr. Andrew Huberman and Dr. Layne Norton cover foundational nutrition science — fat loss, muscle building, metabolism, and more — grounded in mechanistic evidence rather than trend-driven advice. A concise, evidence-based reference you can point clients toward. Listen →
|
Endometriosis and Adenomyosis: Diagnosis, Fertility, Reproductive Aging, and Emerging Treatments
The Peter Attia Drive • June 22, 2026
A good listen for practitioners working with clients navigating unexplained pelvic symptoms or fertility challenges. Dr. Peter Attia and reproductive medicine specialist Renato Tomioka, M.D., Ph.D. cover why endometriosis and adenomyosis remain dramatically underdiagnosed, how advances in MRI are changing diagnostic timelines, and emerging treatment strategies. Adds clinical context behind the diagnosis gaps your clients may be experiencing. Listen →
|
Optimizing GLP-1 Outcomes: Starting, Managing & Discontinuing Therapy
The DUTCH Podcast • June 23, 2026
Worth your time if clients are on or asking about GLP-1 medications. Dr. Jaclyn Smeaton hosts Dr. Bindiya Gandhi for a whole-person look at GLP-1 receptor agonist therapy — covering how to start, manage, and discontinue these medications with a root-cause lens, with particular attention to how GLP-1 therapy intersects with hormones, metabolism, and long-term outcomes. Provides a framework for supporting clients nutritionally before, during, and after treatment. Listen →
|
The PCOS Name Change and What It Means for Women’s Health
The Root Cause Medicine Podcast (Rupa Health) • June 18, 2026
Useful if you work with clients who have polycystic ovary syndrome (PCOS). Dr. Kate Kresge covers the proposed renaming of PCOS — what the name change is, why advocates are pushing for it, and what it could mean for how the condition is understood and treated. A quick 19-minute update with real implications for client education and how practitioners frame the condition in clinical conversations. Listen →
|
Decoding Gut Health with Dr. Megan Rossi
Decoding Women’s Health (Pushkin) • June 16, 2026
A solid episode to recommend to clients who want to understand the science behind gut health recommendations. Dr. Elizabeth Poynor sits down with Dr. Megan Rossi — researcher at King’s College London and founder of The Gut Health Clinic — for a conversation on how the gut microbiome shapes overall wellbeing, with focus on the intersection of gut health and women’s physiology. Research-grounded and accessible. Listen →
|
|
Mark Your Calendar
|
July 1
ADHD in Perimenopause: The Estrogen-Dopamine Connection and Clinical Implications
Live webinar • Doctor’s Data • 12 PM Pacific — Register →
|
July 7
The Estrobolome: How Gut Dysbiosis and Liver Detoxification Shape Estrogen Balance
Live webinar • Doctor’s Data • 12 PM Pacific — Register →
|
July 14
From Macros to Micros: How to Make the Most of Your Nutritional Assessment
Free live virtual webinar • PLMI • 5:00–7:00 PM Pacific — Register →
|
On-Demand
Hidden Exposure: Uncovering Mold-Driven Illness Through Dual Testing
Recorded webinar • Mosaic Diagnostics — Register →
|
June 2026
Optimizing the Athlete
Three-module online course • Genova Diagnostics — Register →
|
|
Tech Tip
|
How to Get Consistent Multi-Slide Graphics from AI Image Tools
If you’ve ever asked an AI image generator to create a second slide “in the same style” as the first — only to watch it subtly (or dramatically) reinvent your design — you’re not alone. Here’s why it happens and how to fix it.
The core problem: AI image generators have no memory. Every new request starts from scratch, which means “keep it the same” is more of a suggestion than a command.
Three techniques that actually work:
- Build a style guide and paste it into every prompt. Don’t say “modern style” — say exactly what you mean: cream background #F5F1E9, charcoal sans-serif headers, deep olive #556B2F accents. Spell out the hex codes every time.
- Treat each slide as a standalone request. Instead of “now do Slide 2,” say: “Create a new, separate square graphic designed to be the next image in a cohesive carousel, visually identical to the attached Slide 1.” Attach the accepted image every time.
- Name what you want to preserve. Bad prompt: “Same style as before.” Better prompt: “Use the exact cream background, bold charcoal font, and olive illustrations from Slide 1.” Specific wins every time.
The bottom line: AI image tools reward precision. The more you lock down your visual variables in writing, the less room there is for creative drift.
|
|
Curated weekly for functional nutrition practitioners.
Like this? Please, please forward it to a colleague • Not subscribed? Sign up at nutrishify.com/subscribeQuestions or feedback? Reply to this email. |
|
